Attenuation of estrogen receptor α-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor

Genes and Development

Volumn 18, Issue 17, 2004, Pages 2134-2146

  Aiyar, Sarah E ^a   Sun, Jian Long ^a,c   Blair, Ashley L ^a   Moskaluk, Christopher A ^a   Lu, Yun Zhe ^a,c   Ye, Qi Nong ^a   Yamaguchi, Yuki ^b   Mukherjee, Amitava ^a   Ren, Da Ming ^c   Handa, Hiroshi ^b   Li, Rong ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c FUDAN UNIVERSITY   (China)

Author keywords

COBRA1; Estrogen; NELF; Nuclear receptor; RNAPII; Transcriptional repression

Indexed keywords

BRCA1 PROTEIN; CELL NUCLEUS RECEPTOR; ELONGATION FACTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; NEGATIVE ELONGATION FACTOR; PROTEIN COBRA1; PROTEIN SUBUNIT; RNA POLYMERASE II; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; ESTROGEN ACTIVITY; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; CELLS, CULTURED; CHROMATIN; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; NUCLEAR PROTEINS; PLASMIDS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA POLYMERASE II; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 4444368456     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1214104     Document Type: Article

References (61)

1. Ainbinder, E., Amir-Zilberstein, L., Yamaguchi, Y., Handa, H., and Dikstein, R. 2004. Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-κB. Mol. Biol. Cell. 24: 2444-2454.
2. Ali, S. and Coombes, R.C. 2002. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2: 101-112.
3. Andrulis, E.D., Guzman, E., Doring, P., Werner, J., and Lis, J.T. 2000. High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: Roles in promoter proximal pausing and transcription elongation. Genes & Dev. 14: 2635-2649.
4. Augereau, P., Miralles, F., Cavailles, V., Gaudelet, C., Parker, M., and Rochefort, H. 1994. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8: 693-703.
5. Baniahmad, C., Nawaz, Z., Baniahmad, A., Gleeson, M.A., Tsai, M.J., and O'Malley, B.W. 1995. Enhancement of human estrogen receptor activity by SPT6: A potential coactivator. Mol. Endocrinol. 9: 34-43.
6. Bentley, D. 2002. The mRNA assembly line: Transcription and processing machines in the same factory. Curr. Opin. Cell Biol. 14: 336-342.
7. Berry, M., Nunez, A.-M., and Chambon, P. 1989. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. 86: 1218-1222.
8. Bissell, M.J. and Radisky, D. 2001. Putting tumors in context. Nat. Rev. Cancer 1: 46-54.
9. Briggs, S.D., Sharkey, M., Stevenson, M., and Smithgall, T.E. 1997. SH3-meidated HckTyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 972: 17899-17902.
10. Cheung, P., Tanner, K.G., Cheung, W.L., Sassone-Corsi, P., Denu, J.M., and Allis, C.D. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5: 905-915.
11. de la Mata, M., Alonso, C.R., Kadener, S., Fededa, J.P., Blaustein, M., Pelisch, F., Cramer, P., Bentley, D., and Kornblihtt, A.R. 2003. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12: 525-532.
12. Debnath, J., Muthuswamy, S.K., and Brugge, J.S. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
13. Fan, S., Wang, J., Yuan, R., Ma, Y., Meng, Q., Erdos, M.R., Pestell, R.G., Yuan, F., Auborn, K.J., Goldberg, I.D., et al. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284: 1354-1356.
14. Fan, S., Ma, Y.X., Wang, C., Yuan, R.Q., Meng, Q., Wang, J.A., Erdos, M., Goldberg, I.D., Webb, P., Kushner, P.J., et al. 2001. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20: 77-87.
15. Fernandes, I., Bastien, Y., Wai, T., Nygard, K., Lin, R., Cormier, O., Lee, H.S., Eng, F., Bertos, N.R., Pelletier, N., et al. 2003. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11: 139-150.
16. Foster, J.S., Henley, D.C., Ahamed, S., and Wimalasena, J. 2001. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 12: 320-327.
17. Freeman, B.C. and Yamamoto, K.G. 2002. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296: 2232-2235.
18. Glass, C.K. and Rosenfeld, M.G. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes & Dev. 14: 121-141.
19. Green, S. and Chambon, P. 1986. A superfamily of potentially oncogenic hormone receptors. Nature 324: 615-617.
20. Guo, S., Yamaguchi, Y., Schilbach, S., Wada, T., Lee, J., Goddard, A., French, D., Handa, H., and Rosenthal, A. 2000. A regulator of transcriptional elongation controls vertebrate neuronal development. Nature 408: 366-369.
21. Hartzog, G.A., Wada, T., Handa, H., and Winston, F. 1998. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes & Dev. 12: 357-369.
22. Hu, Y.-H. and Li., R 2002. JunB Potentiates function of BRCA1 activation domain 1(AD1) through a coiled-coil-mediated interaction. Genes & Dev. 16: 1509-1517.
23. Hu, Y.-F., Miyake, T., Ye, Q., and Li, R. 2000. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain. J. Biol. Chem. 275: 40910-40915.
24. Jacks, T. and Weinberg, R.A. 2002. Taking the study of cancer cell survival to a new dimension. Cell 111: 923-925.
25. Kaplan, C.D., Morris, J.R., Wu, C.T., and Winston, F. 2000. Spt5 and Spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes & Dev. 14: 2623-2634.
26. Kaplan, C.D., Laprade, L., and Winston, F. 2003. Transcription elongation factors repress transcription initiation from cryptic sites. Science 301: 1096-1099.
27. Kim, J.H., Li, H., and Stallcup, M.R. 2003. CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol. Cell 12: 1537-1549.
28. Kushner, P.J., Agard, D.A., Greene, G.L., Scanlan, T.S., Shiau, A.K., Uht, R.M., and Webb, P. 2000. Estrogen receptor pathways to AP-1. Steroid Biochem. Mol. Biol. 74: 311-317.
29. Li, R., Knight, J.D., Jackson, S.P., Tjian, R., and Botchan, M.R. 1991. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65: 493-505.
30. Lonard, D.M., Nawaz, Z., Smith, C.L., and O'Malley, B.W. 2000. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol. Cell 5: 939-948.
31. Mandal, S.S., Chu, C., Wada, T., Handa, H., Shatkin, A.J., and Reinberg, D. 2004. Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II. Proc. Natl. Acad. Sci. 101: 7572-7577.
32. Maniatis, T. and Reed, R. 2002. An extensive network of coupling among gene expression machines. Nature 416: 499-506.
33. Mattingly, R.R., Sorisky, A., Brann, M.R., and Macara, I.G. 1994. Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the RasGTPase-activating protein SH3 domain. Mol. Cell. Biol. 14: 7943-7952.
34. Mazumdar, A., Wang, R.A., Mishra, S.K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R.K., and Kumar, R. 2000. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell. Biol. 3: 30-37.
35. McKenna, N.J. and O'Malley, B.W. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.
36. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M., and Gannon, F. 2003. Estrogen receptor-a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
37. Narita, T., Yamaguchi, Y., Yano, K., Sugimoto, S., Chanarat, S., Wada, T., Kim, D.K., Hasegawa, J., Omori, M., Inukai, N., et al. 2003. Human transcription elongation factor NELF: Identification of novel subunits and reconstitution of the functionally active complex. Mol. Cell. Biol. 23: 1863-1873.
38. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pattersson, K., Warner, M., and Gustafsson, J.A. 2001. Mechanisms of estrogen action. Physiol. Rev. 81: 1535-1565.
39. Norris, J.D., Fan, D., Wagner, B.L., and McDonnell, D.P. 1996. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol. Endocrinol. 10: 1605-1616.
40. Orphanides, G. and Reinberg, D. 2000. RNA polymerase II elongation through chromatin. Nature 407: 471-475.
41. -. 2002. A unified theory of gene expression. Cell 108: 439-451.
42. Persson, I. 2000. Estrogens in the causation of breast, endometrial, and ovarian cancers: Evidence and hypotheses from epidemiological findings. Steroid Biochem. Mol. Biol. 74: 357-364.
43. Ronnov-Jessen, L., Petersen, O.W., and Bissell, M.J. 1996. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol. Rev. 76: 69-125.
44. Salghetti, S.E., Kim, S.Y., and Tansey, W.P. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J. 18: 717-726.
45. Saunders, A., Werner, J., Andrulis, E.D., Nakayama, T., Hirose, S., Reinberg, D., and Lis, J.T. 2003. Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo. Science 301: 1094-1096.
46. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A., and Brown, M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
47. Shao, W., Halachmi, S., and Brown, M. 2002. ERAP140, a conserved tissue-specific nuclear receptor coactivator. Mol. Cell. Biol. 22: 3358-3372.
48. Townson, S.M., Kang, K., Lee, A.V., and Oesterreich, S. 2004. Structure-function analysis of the estrogen receptor α corepressor scaffold attachment factor-B1: Identification of a potent transcriptional repression domain. J. Biol. Chem. 279: 26074-26081.
49. Tremblay, G.B., Tremblay, A., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Labrie, F., and Giguere, V. 1997. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol. 11: 353-365.
50. Wada, T., Orphanides, G., Hasegawa, J., Kim, D.K., Shima, D., Yamaguchi, Y., Fukuda, A., Hisatake, K., and Handa, H. 2000. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol. Cell 5: 1067-1072.
51. Weigel, N.L. and Zhang, Y. 1998. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76: 469-479.
52. Wijayaratne, A.L. and McDonnell, D.P. 2001. The human estrogen receptor α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276: 35684-35692.
53. Winston, F. 2001. Control of eukaryotic transcription elongation. Genome Biol. 2: 1006.1-1006.3.
54. Wu, G.S., Saftig, P., Peters, C., and El-Deiry, W.S. 1998. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16: 2177-2183.
55. Wu, C.-H., Yamaguchi, Y., Benjamin, L.R., Horvat-Gordon, M., Washinsky, J., Enerly, E., Larsson, J., Lambertsson, A., Handa, H., and Gilmour, D. 2003. NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes & Dev. 17: 1402-1414.
56. Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., and Handa, H. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
57. Yamaguchi, Y., Inukai, N., Narita, T., Wada, T., and Handa, H. 2002. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol. 22: 2918-2927.
58. Ye, Q., Chung, L.W., Cinar, B., Li, S., and Zhau, H.E. 2000. Identification and characterization of estrogen receptor variants in prostate cancer cell lines. J. Steriod Biochem. Mol. Biol. 75: 21-31.
59. Ye, Q., Hu, Y.F., Zhong, H., Nye, A.C., Belmont, A.S., and Li, R. 2001. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J. Cell Biol. 155: 911-921.
60. Zheng, L., Annab, L.A., Afshari, C.A., Lee, W.H., and Boyer, T.G. 2001. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. 98: 9587-9592.
61. Zorio, D.A.R. and Bentley, D.L. 2001. Transcription elongation: The 'Foggy' is lifting. Curr. Biol. 11: R114-R146.